Two decades after the WHI alarms, the picture is more nuanced, and protecting bone is part of the conversation.
Few topics in women's health have swung as dramatically as menopausal hormone therapy. A March 2026 review looks back on more than twenty years of lessons from the Women's Health Initiative, and it's a thoughtful reckoning rather than a new trial, so I read it as “here's what we've learned,” not “here's a fresh discovery.”
The headline is nuance. Hormone therapy went from widely prescribed, to widely feared after the early WHI findings, to where we are now: understood as something that can carry real benefits and real risks depending on the individual woman, her age, her timing, and her health history.
For bone, this matters. Hormone therapy has meaningful effects on the skeleton, and protecting bone is one of the considerations that belongs in the conversation, not the only one, but a genuine part of it.
What two decades have taught us, more than anything, is that there's no one-size-fits-all answer here. The right decision is individual, made carefully with a clinician who knows you.
If you're navigating menopause and weighing your options, your bones deserve a seat at that table. Bring them into the discussion.
Wondering about your own bone health?
Book a ConsultationA peer-reviewed review of more than two decades of evidence from the Women's Health Initiative on menopausal hormone therapy, emphasizing an individualized, nuanced approach in which bone protection is one consideration among several.
